Apparatus automatic thickness measurement of the measurement subject
KR20160132559A
Toxicity Prediction Model for Acute Toxicity by Oral Route based on Quantitative Structure-Toxcity Relationships with Non-linear Machine Learning Methods
KR20160127487A
Boiling-Point Prediction Model based on Quantitive Structure-Activity Relationships with Linear and Non linear Machine Learning Methods
KR20160127486A
Melting-Point Prediction Model based on Quantitive Structure-Activity Relationships with Linear and Non linear Machine Learning Methods
WO2016013725A1
Pharmaceutical composition containing, as active ingredient, granulocyte-colony stimulating factor mutant protein or transferrin fusion protein thereof
KR20160012059A
Pharmaceutical compositions comprising mutant proteins of Granulocyte-colony stimulating factor or transferrin fusion proteins thereof
KR101543666B1
Punching machine with 4 driving axis for multilayer printed circuit board
KR20140104078A
Pallet unit and workpiece transfering apparatus having the same
KR20140100067A
Apparatus for automatic bondig release films for cover-lay laminating in Flexible Printed Circuit Board
KR20140100063A
Drilling machine for multilayer printed circuit board
KR20140075082A
Dihydroquinoline derivatives, preparation method thereof and pharmaceutically composition containing the same as an active ingredient for preventing or treatment of disease by influenza A virus
KR20110129340A
NOVEL DERIVATIVES INHIBITING ACTIVITY OF 11BETA-HSD1 (11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1) ENZYME, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT
WO2011149213A2
Novel derivative having inhibitory activity against 11β-hsd1, preparation method thereof, and pharmaceutical composition containing same as active ingredient
KR20120097861A
Novel phenylurea or phenylthiourea derivatives, pharmaceutically acceptable salts thereof, preparation method thereof and pharmaceutical composition for prevention or treatment of diseases induced by influenza virus containing the same as an active ingredient
KR20120048223A
2-phenyl-4-[3-(substituted-sulfonyl)arylino]quinazoline derivatives, phamaceutically acceptable salt thereof preparation method thereof and phamaceutical composition for prevention or treatment of the hepatitis c as an active ingredient
KR20110097448A
A composition containing of novel imidazole pyrazine compound having influenza virus activity for treating antivirus
KR20110040384A
Novel 4-phenyl-benzimidazole or 4-phenyl-benzoxazole derivates or pharmaceutically acceptable salts thereof, preparation method thereof and pharmaceutical compositions for antivirus containing the same as an active gredient
KR20100043311A
Novel 4-aryl-4-oxobutanoic acid amide derivates or pharmaceutically acceptable salts thereof, preparation method thereof and pharmaceutical compositions containing the same as an active gredient
